Close Menu
    What's Hot

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    January 14, 2026

    Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

    January 14, 2026

    CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

    January 14, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      Is It Time to Rate Life ILS Structures?

      October 22, 2025

      Stability Continues in US Life Insurer Ownership and Solvency Metrics

      January 14, 2026

      Third Quarter Sets New US Annuity Sales Record

      December 10, 2025

      US Life Insurance Industry Retreats Slightly in 2024 but Remains Healthy Fundamentally

      December 10, 2025

      Stress Test Results Find UK Life Insurance Industry in Rude Health

      November 26, 2025

      NG Bailey Pension and Life Assurance Plan Completes Bulk Purchase Annuity Buy-In With PIC

      January 12, 2026

      Utmost Group Sells Life and Pensions Business to JAB Insurance

      December 22, 2025

      Skanska Pension Fund Completes Bulk Purchase Annuity Buy-In With Standard Life

      December 22, 2025

      Peel Ports Final Salary Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

      December 22, 2025

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      Q&A: James Hadley, Senior Consultant, Barnett Waddingham

      November 26, 2025

      Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

      January 14, 2026

      Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

      January 14, 2026

      European Life Settlement Association Announces 2026 Executive Committee Officers

      January 12, 2026

      Kosmos Management Acquires Three Funds from RiverRock Asset Management

      January 5, 2026

      Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

      January 14, 2026

      Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

      January 14, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Stability Continues in US Life Insurer Ownership and Solvency Metrics

      January 14, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025

      Editor’s Letter – Volume 4, Issue 9, September 2025

      September 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    The Legacy of the Pandemic for Pension Scheme Mortality

    Mortality February 8, 2023By Stuart McDonald
    Covid-19 Resilience
    Share
    Twitter LinkedIn Email

    The Covid-19 pandemic has caused a dramatic shock to health and life expectancy, disrupting the pattern of mortality improvement seen historically in the UK population.

    Since March 2020, we have witnessed over 160,000 excess deaths compared to what would have been expected if mortality rates had remained at pre-pandemic levels. Early on, the vast majority of excess deaths were a direct consequence of Covid infections. As time goes on though we are increasingly also seeing excess deaths arise from indirect impacts of the pandemic such as disruption to the health system and changes to individual health-seeking behaviour. Medical diagnoses have been missed or delayed – for example, 2020 saw large falls in new prescriptions to manage blood pressure and cholesterol levels, which have not been caught up. In December 2022 the average ambulance response time in England for category 2 calls (which can include strokes and heart attacks) was over one and a half hours. That is against a target of 18 minutes.

    Whilst most direct deaths from Covid-19 were among older people, the relative increase in mortality rates was broadly comparable across all age groups in 2020. As time has gone on and indirect impacts have increasingly influenced mortality rates, it is younger adults experiencing the biggest relative increase. Many of these excess deaths are from cardiovascular causes.

    Age is certainly not the only relevant lens through which to view the impacts of Covid-19. Clear differences have been apparent at various stages of the pandemic when looking at other demographic, geographic and socioeconomic indicators. For example, the most deprived fifth of the population experienced disproportionately high excess mortality during the first wave. This was partly because they were more likely to be in occupations that exposed them to the virus, and partly due to prevalence of health conditions that made serious illness and death more likely.

    The pandemic presents a significant challenge to pension scheme trustees and sponsors on the allowance that should be made for Covid-19 when adopting mortality assumptions for their schemes. When giving advice on mortality assumptions, actuaries tend to use models which project future mortality rates based on past data. Given the volatility of recent data, these models may now produce unreliable forecasts or require more significant subjective adjustment than previously. The latest model of mortality improvement from the Continuous Mortality Investigation (CMI) makes no allowance for Covid-19 by default.

    This means that it has never been more important to understand the underlying drivers of changes to mortality, and how these affect different groups. Some drivers will have a comparable impact on all of society, but others may affect members of a specific pension scheme differently to other pension schemes or the general population. For example, a scheme’s membership might be concentrated in a region where waiting lists are particularly long and the local population’s unmet healthcare needs are significant.  

    Even before the pandemic struck, there was extreme longevity inequality in the UK, with an astonishing 27-year gap between the life expectancy at birth of men in the local areas with the highest and lowest life expectancy. The life expectancy gap was widening pre-pandemic and we expect it to continue to do so for at least the next few years. What happens beyond that is harder to say as it depends in large part on political choices. One of the UK Government’s “Grand Challenge” missions is to “ensure that people can enjoy at least five extra healthy, independent years of life by 2035, which narrowing the gap between the experience of the richest and poorest”. The Covid-19 pandemic will make this ambitious goal even more challenging to deliver.

    Stuart McDonald is a Partner and Head of Longevity and Demographic Insights at Lane Clark & Peacock LLP


    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association

    2023 - February Clinical Mortality Commentary Longevity Risk Volume 2 Issue 2 - February 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Stability Continues in US Life Insurer Ownership and Solvency Metrics

    January 14, 2026By Roger Lawrence

    Still Hot and Bothered?

    December 22, 2025By Amy Walker

    New Reports Suggest Life Settlement Market in ‘Confident Evolution’

    December 10, 2025By Greg Winterton

    US Life Insurance Industry Retreats Slightly in 2024 but Remains Healthy Fundamentally

    December 10, 2025By Roger Lawrence
    Latest Issue

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    January 14, 2026

    Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

    January 14, 2026

    CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

    January 14, 2026

    Stability Continues in US Life Insurer Ownership and Solvency Metrics

    January 14, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.